(Q84539941)
Statements
Phase IB study of the combination of docetaxel, gemcitabine, and bevacizumab in patients with advanced or recurrent soft tissue sarcoma: the Axtell regimen (English)
S-J Lee
S Movva
L A Cerilli
S Eberhardt
B Schmit
R Quinn
C Y Muller
I Rabinowitz
M Purdy
D Snyder